Venetron (Apocynum venetum)

Venetron is a standardized extract of Apocynum venetum containing hyperoside and isoquercitrin that supports sleep quality and stress management. Clinical trials demonstrate its ability to promote relaxation and reduce stress biomarkers through GABA-ergic activity modulation.

Origin & History

Venetron is a patented, purified powdered extract derived from the leaves of Apocynum venetum L., a perennial rhizomatous plant used in Traditional Chinese Medicine and as food/tea. The extraction involves aqueous ethanol at 60°C, filtration, purification through synthetic adsorbent resin, and concentration into a dark brown powder standardized to at least 2-4% hyperoside and 2-4% isoquercitrin by HPLC.

Historical & Cultural Context

Apocynum venetum (also known as rafuma) has been used for centuries in Traditional Chinese Medicine as an herb, food, and tea, valued for pharmacological effects from its leaves. Historical uses align with its ecological, medicinal, and economic roles as a perennial plant.

Health Benefits

• Improves sleep quality - supported by placebo-controlled trial and dedicated sleep study (PMID: 40409574) showing sleep-promoting effects
• Reduces stress markers - clinical trial demonstrated reduction in chromogranin A, a stress biomarker
• Enhances quality of life - placebo-controlled trial in females showed improvements with 50mg daily dose
• May support weight management - preclinical evidence shows isoquercitrin inhibits AMPK/SREBP-1c signaling and glucose uptake
• Provides antioxidant support - contains flavonoids and polyphenols that reduce oxidative/nitrosative stress

How It Works

Venetron's primary bioactive compounds hyperoside and isoquercitrin modulate GABAergic neurotransmission, enhancing the activity of GABA receptors in the central nervous system. The extract also influences the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol and chromogranin A release during stress responses. These compounds may additionally affect serotonin and dopamine pathways, contributing to mood stabilization and sleep promotion.

Scientific Research

Venetron has been evaluated in placebo-controlled human clinical trials, including one in females using 50 mg daily showing improvements in quality of life, sleep, and stress markers. A recent study (PMID: 40409574) specifically assessed sleep-promoting effects of Venetron from A. venetum leaf extract and its mechanisms. Safety was confirmed in human clinical trials with no significant adverse effects reported.

Clinical Summary

A placebo-controlled trial demonstrated Venetron's sleep-promoting effects with significant improvements in sleep quality scores (PMID: 40409574). Clinical research showed measurable reductions in chromogranin A, a validated stress biomarker, indicating objective stress reduction. A dedicated sleep study confirmed sleep latency improvements and enhanced sleep efficiency. However, most studies are relatively small-scale, and larger long-term trials are needed to establish optimal dosing protocols.

Nutritional Profile

Venetron is a standardized extract of Apocynum venetum (Luo Bu Ma) leaves, not consumed as a whole food, so traditional macronutrient/micronutrient profiling is not applicable in the conventional sense. The extract is standardized primarily for its bioactive flavonoid content. Key bioactive compounds include: hyperoside (hyperin) at approximately 1–3% of extract dry weight, isoquercitrin (quercetin-3-O-glucoside) at approximately 1–2%, chlorogenic acid at trace-to-low concentrations, and quercetin derivatives collectively representing the dominant polyphenol fraction. The commercially standardized Venetron extract (as used in clinical trials at 50mg daily doses) is standardized to contain a defined flavonoid profile with hyperoside and isoquercitrin as marker compounds. Raw Apocynum venetum leaves contain total flavonoids at approximately 3–8% of dry weight, rutin at approximately 0.5–1.5%, and tannins at low concentrations. The plant also contains small amounts of potassium, calcium, and magnesium as minerals, and trace amounts of vitamins, though these are not clinically relevant at extract doses. Bioavailability: flavonoid glycosides such as hyperoside and isoquercitrin undergo intestinal hydrolysis to their aglycone forms (quercetin) prior to absorption; bioavailability is moderate and enhanced when taken with food. No significant protein, fat, or dietary fiber contribution at standard 50mg extract doses.

Preparation & Dosage

Clinically studied dose: 50 mg daily of Venetron extract standardized to ≥2% hyperoside and ≥2% isoquercitrin, as used in placebo-controlled trials for sleep and quality of life benefits. The branded extract is the primary form tested in clinical research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, Magnesium glycinate, Ashwagandha, Passionflower, Valerian root

Safety & Interactions

Venetron appears well-tolerated in clinical studies with no serious adverse effects reported at standard dosages. Potential mild side effects may include drowsiness or digestive upset in sensitive individuals. The extract may enhance the effects of sedative medications, anti-anxiety drugs, or sleep aids, requiring medical supervision when combined. Safety during pregnancy and breastfeeding has not been established, so use should be avoided during these periods.